Anemia and Erythropoietin
Astor BC, Muntner P, Levin A, et al: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162:1401-1408, 2002
Becker BN, Becker YT, Leverson GE, et al: Erythropoietin therapy may retard progression in chronic renal transplant dysfunction. Nephrol Dial Transplant 17:1667-1673, 2002
Eiselt J, Racek J, Opatrny K, Jr.: Oxidative stress: the effect of erythropoietin and the dialysis membrane. Int J Artif Organs 23:33-40, 2000
Foley RN: Should hemoglobin be normalized in uremic patients? Clin Nephrol 58: S58-S61, 2002 (Suppl 1)
Hudson JQ, Sameri RM: Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease. Pharmacotherapy 22:141S-149S, 2002 (9 Pt 2)
Kammerer J, Ratican M, Elzein H, et al: Anemia in CKD: prevalence, diagnosis, and treatment. Case study of the anemic patient. Nephrol Nurs J 29:371-374, 2002
Levin A: The relationship of haemoglobin level and survival: direct or indirect effects? Nephrol Dial Transplant 17:8-13, 2002 (Suppl 5)
London R, Solis A, Goldberg GA, et al: Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 40:539-548, 2002
Usberti M, Gerardi G, Bufano G, et al: Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 40:590-599, 2002
Chronic Kidney Failure
Cekin AH, Boyacioglu S, Gursoy M, et al: Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors. Am J Gastroenterol 97:1352-1356, 2002
Jansen MA, Hart AA, Korevaar JC, et al: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046-1053, 2002
Kausz AT, Levey AS: The care of patients with chronic kidney disease. J Gen Intern Med 17:658-662, 2002
Koizumi T, Murakami K, Nakayama H, et al: Role of dietary phosphorus in the progression of renal failure. Biochem Biophys Res Commun 295:917-921, 2002
Lea JP, Nicholas SB: Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc 94:7S-15S, 2002 (Suppl 8)
Tarver-Carr ME, Powe NR, Eberhardt MS, et al: Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States: A Population-Based Study of Potential Explanatory Factors. J Am Soc Nephrol 13:2363-2370, 2002
Tasanarong A, Seublinvong T, Eiam-Ong S: The role of carbamylated hemoglobin in identifying acute and chronic renal failure. J Med Assoc Thai 85:462-469, 2002
Dialysis
Curtin RB, Mapes DL: Health care management strategies of long-term dialysis survivors. Nephrol Nurs J 28:385-392, 2001
Lee H, Manns B, Taub K, et al: Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622, 2002
van Manen JG, Korevaar JC, Dekker FW, et al: How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 40:82-89, 2002
Lipids
Fatica RA, Dennis VW: Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders. Cleve Clin J Med 69:S21-S27, 2002 (Suppl 3)
Fung F, Sherrard DJ, Gillen DL, et al: Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40:307-314, 2002
Maccarrone M, Manca-di-Villahermosa S, Meloni C, et al: Arachidonate cascade, apoptosis, and vitamin E in peripheral blood mononuclear cells from hemodialysis patients. Am J Kidney Dis 40:600-610, 2002
Muscari A, Puddu GM, Puddu P: Lipid-lowering drugs: are adverse effects predictable and reversible? Cardiology 97:115-121, 2002
Siems W, Quast S, Carluccio F, et al: Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 58:S12-S19, 2002 (Suppl 1)
Suliman ME, Stenvinkel P, Heimburger O, et al: Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. Am J Kidney Dis 40:480-488, 2002
Nutrition: Clinical
Cooper BA, Bartlett LH, Aslani A, et al: Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 40:126-132, 2002
Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347:738-748, 2002
Fein PA: Safety of PEG tubes in peritoneal dialysis patients. Semin Dial 15:213-214, 2002
Headley S, Germain M, Mailloux P, et al: Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis 40:355-364, 2002
Kuriyama S, Tsuji I, Ohkubo T, et al: Medical care expenditure associated with body mass index in Japan: the Ohsaki Study. Int J Obes Relat Metab Disord 26:1069-1074, 2002
Lindsay R: The nutritional status of chronic renal failure patients following the initiation of hemodialysis treatment. Am J Kidney Dis 40:205-207, 2002
Mehrotra R, Berman N, Alistwani A, et al: Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis 40:133-142, 2002
Mistiaen P: Thirst, interdialytic weight gain, and thirst-interventions in hemodialysis patients: a literature review. Nephrol Nurs J 28:601-603, 2001
Mitch WE: Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437-439, 2002
Pupim LB, Kent P, Caglar K, et al: Improvement in nutritional parameters after initiation of chronic hemodialysis. Am J Kidney Dis 40:143-151, 2002
Pupim LB, Flakoll PJ, Brouillette JR, et al: Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 110:483-492, 2002
Vanherweghem JL: Chinese herbs nephropathy: not merely a trivial matter of a name. Am J Kidney Dis 40:218, 2002
Nutrition: Metabolism and Basic Science
Aggarwal A, Kabbani SS, Rimmer JM, et al: Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Am J Kidney Dis 40:315-322, 2002
Bertelli AA, Migliori M, Panichi V, et al: Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci 957:230-238, 2002
Norton PA: Affect of serum leptin on nutritional status in renal disease. J Am Diet Assoc 102:1119-1125, 2002
Sowers JR: Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346:1999-2001, 2002
Szymanski N: Infection and inflammation in dialysis patients: impact on laboratory parameters and anemia. Case study of the anemic patient. Nephrol Nurs J 28:337-340, 2001
Pediatrics
Furth SL, Hwang W, Yang C, et al: Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450-455, 2002
Hattori S, Yosioka K, Honda M, et al: The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 17:456-461, 2002
Mehls O, Schaefer F, Tonshoff B, et al: Effectiveness of growth hormone treatment in short children with chronic renal failure. J Pediatr 141:147-148, 2002
Parekh RS, Carroll CE, Wolfe RA, et al: Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197, 2002
Renal Bone Disease
Brossard JH, Yamamoto LN, D'Amour P: Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications. Semin Dial 15:196-201, 2002
Friedman TC, Norris KC: The role of vitamin D in mild to moderate chronic kidney disease. Trends Endocrinol Metab 13:189-194, 2002
Vitamins and Minerals
Boero R, Pignataro A, Quarello F: Salt intake and kidney disease. J Nephrol 15:225-229, 2002
Elian KM, Hoffer LJ: Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease. Metabolism 51:881-886, 2002
Fernandez-Real JM, Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002
Reddy ST, Wang CY, Sakhaee K, et al: Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40:265-274, 2002
Rowe IA: Mineral metabolism and vascular disease in patients with end-stage renal failure. JAMA 288:695-696, 2002
Schaefer RM, Teschner M, Kosch M: Folate metabolism in renal failure. Nephrol Dial Transplant 17:24-27, 2002 (Suppl 5)
Wilmer WA, Magro CM: Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15:172-186, 2002
FULL TEXT